Wenyong Tong

Company: Merck & Co

Job title: Principal Scientist

Seminars:

Engineered Cell Lines vs. Cancer Cell Lines for Conventional Antibody-Drug Conjugate (ADC) Cell-Based Potency Assay Development 4:45 pm

Testing ADC potency through cytotoxicity assays, evaluating the tumor-killing activity of the payload following antibody internalization Ensuring assay robustness and specificity through the selection of a target antigen-expressing cell lineRead more

day: Day One